The ability of SARS-CoV-2 S1-stimulated CD4+, CD8+ T, and NK cells from the COVID-19-recovered groups and healthy individuals to express IFN-γ/CD107a as a marker of cytotoxicity was assessed in flowcytometry. This evidence concerns the gene CD8A and COVID-19.